NCT07192211RecruitingPhase 2
Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG
Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo Coronary Artery Bypass Surgery
Source: ClinicalTrials.gov · Last updated 9 Jun 2026
Brief summary (registry, in English)
ADR-002K is administered to heart failure patients with ischemic heart disease who undergo coronary artery bypass surgery (CABG) to investigate its efficacy and safety.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 28 Aug 2025
- Start date
- 28 Apr 2026
- Primary completion date
- 30 Sept 2028
- Lead sponsor
- Rohto Pharmaceutical Co., Ltd.
- Diseases
- Heart failure, Coronary artery disease
- NCT number
- NCT07192211
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 50
- From 28 Apr 2026 to the primary completion date, 30 Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have developed acute coronary syndrome within 3 months prior to obtaining consent.
Other illness
- Patients who have a combination of cardiovascular disease such as severe organic valvular disease.
Other
- Others
Who the study is looking for
- Patients clinically diagnosed with chronic heart failure due to ischemic heart disease who undergo CABG
- Patients with an LVEF of less than 40% as determined by the cardiac ultrasound at the screening examination.
- Others
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Osaka Hospital Coordinator of this site? Confirm its status | Osaka | Japan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.